FRANKFURT – Fresenius (NYSE: FMS) said it was checking options to speed up the start of new production lines of
1 year ago
German healthcare group Fresenius (NYSE: FMS) beat second-quarter operating profit expectations on Wednesday, citing strong performance at its Kabi and
2 years ago
The world’s largest dialysis specialist Fresenius Medical Care (NYSE: FMS) cut the outlook for volumes in its key U.S. market
Shares of leading dialysis services providers, including DaVita Inc. (NYSE: DVA) and German competitor Fresenius Medical Care (NYSE: FMS), witnessed